This HTML5 document contains 110 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

Prefix	IRI
wdt	http://www.wikidata.org/prop/direct/
wdtn	http://www.wikidata.org/prop/direct-normalized/
n11	http://dx.doi.org/10.1016/
schema	http://schema.org/
skos	http://www.w3.org/2004/02/skos/core#
rdfs	http://www.w3.org/2000/01/rdf-schema#
wikibase	http://wikiba.se/ontology#
p	http://www.wikidata.org/prop/
rdf	http://www.w3.org/1999/02/22-rdf-syntax-ns#
n10	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdh	http://www.w3.org/2001/XMLSchema#
wds	http://www.wikidata.org/entity/statement/
wd	http://www.wikidata.org/entity/

Statements

Subject Item

wd:Q34707632

rdf:type

wikibase:Item

schema:description

artículu científicu espublizáu en 1982 1982年論文 мақолаи илмӣ 1982年論文 teaduslik artikkel vědecký článek 1982 թվականի մարտին հրատարակված գիտական հոդված 1982年论文 wetenschappelijk artikel artikulong pang-agham سائنسی مضمون 1982年论文 vetenskaplig artikel научная статья naučni članak tieteellinen artikkeli scienca artikolo مقالهٔ علمی სამეცნიერო სტატია บทความทางวิทยาศาสตร์ 1982年论文 bài báo khoa học 1982 nî lūn-bûn מאמר מדעי articol științific artykuł naukowy ১৯৮২-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ 1982年の論文 vitenskapelig artikkel 1982年论文 artigo científico (publicado na 1982) научни чланак artikull shkencor 1982年論文 научна статия artigo científico мақолаи илмӣ article scientifique (publié 1982) artigo científico (publicado na 1982) tudományos cikk article scientific 1982年論文 1982 թուականի Մարտին հրատարակուած գիտական յօդուած wissenschaftlicher Artikel наукова стаття, опублікована в березні 1982 bilimsel makale 1982年論文 vitskapeleg artikkel 1982年论文 vedecký článok articolo scientifico scientific article научни чланак 1982年论文 مقالة علمية επιστημονικό άρθρο article científic videnskabelig artikel (udgivet 1982) mokslinis straipsnis 1982년 논문 artículo científico publicado en 1982

p:P577

wds:Q34707632-453ED6C2-3FE8-4B21-8AA6-048757C5E06D

wdt:P577

1982-03-01T00:00:00Z

p:P407

wds:Q34707632-38C2BDAD-AA2D-409D-B68A-D32899A19624

wdt:P407

wd:Q1860

p:P2093

wds:Q34707632-2A4BFA3D-D06B-48C6-9400-4CE59132CF39 wds:Q34707632-6C436B4D-8DAD-4FA1-93CF-37475583F73B wds:Q34707632-121D92ED-6C5D-4DB4-86CD-16A5A188F3A5 wds:Q34707632-1FEB885D-3F39-4B05-89E4-2B7647A2E5A7 wds:Q34707632-0BE183BB-7F06-46E4-84D6-A09792E7D2A2

wdt:P2093

Logue M Growdon JH Wurtman RJ Hefti F Melamed E

rdfs:label

Effects of oral L-tyrosine administration on CSF tyrosine and homovanillic acid levels in patients with Parkinson's disease Effects of oral L-tyrosine administration on CSF tyrosine and homovanillic acid levels in patients with Parkinson's disease Effects of oral L-tyrosine administration on CSF tyrosine and homovanillic acid levels in patients with Parkinson's disease

skos:prefLabel

Effects of oral L-tyrosine administration on CSF tyrosine and homovanillic acid levels in patients with Parkinson's disease Effects of oral L-tyrosine administration on CSF tyrosine and homovanillic acid levels in patients with Parkinson's disease Effects of oral L-tyrosine administration on CSF tyrosine and homovanillic acid levels in patients with Parkinson's disease

schema:name

Effects of oral L-tyrosine administration on CSF tyrosine and homovanillic acid levels in patients with Parkinson's disease Effects of oral L-tyrosine administration on CSF tyrosine and homovanillic acid levels in patients with Parkinson's disease Effects of oral L-tyrosine administration on CSF tyrosine and homovanillic acid levels in patients with Parkinson's disease

p:P1476

wds:Q34707632-D826622E-BFA9-4DCF-B1A8-2D3D35671229

wdt:P1476

Effects of oral L-tyrosine administration on CSF tyrosine and homovanillic acid levels in patients with Parkinson's disease

p:P304

wds:Q34707632-D0AAAC14-6D1A-43BB-80E0-0FE01FFDD262

wdt:P304

827-832

p:P31

wds:Q34707632-BBD84102-7BC7-4203-B32C-94116396928C

wdt:P31

wd:Q13442814

p:P921

wds:Q34707632-F2298F75-64E6-4BD3-A134-90C1DBF84516

wdt:P921

wd:Q11085

p:P698

wds:Q34707632-C9579775-1DA0-4A8E-ACEA-7838A9F770EC

wdtn:P698

n10:6175872

wdt:P698

6175872

p:P1433

wds:Q34707632-CCE3B0F1-9498-4053-803B-2D44213DD1C2

wdt:P1433

wd:Q5256275

p:P433

wds:Q34707632-2806A4EA-7642-4105-AEE9-A17BDAA4D208

p:P478

wds:Q34707632-3C21F059-E1D3-44FB-9E7A-74F4BADBD9E8

wdt:P433

10

wdt:P478

30

p:P356

wds:Q34707632-9342CDA0-64D9-4BC8-8A37-3E7525981B98

wdtn:P356

n11:0024-3205(82)90596-3

wdt:P356

10.1016/0024-3205(82)90596-3

skos:altLabel

Effects of oral L-tyrosine administration of CSF tyrosine and homovanillic acid levels in patients with Parkinson's disease

p:P8608

wds:Q34707632-0E647B01-3281-4746-8AEB-83F822B4E9CD

wdt:P8608

release_nbkvshfmrzbsxpiltbpib73ady

p:P5875

wds:Q34707632-D0B994B6-7955-4332-8918-01E6C851417F

wdt:P5875

51287119